Dimensional Fund Advisors
TRAW icon

Dimensional Fund Advisors’s Traws Pharma TRAW Stock Holding History

Dimensional Fund Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-894
Closed -$41K – 3535
2022
Q1 		$41K Sell
894
-113
-11% -$5.24K ﹤0.01% 3473
2021
Q4 		$64K Hold
1,007
– – ﹤0.01% 3469
2021
Q3 		$96K Sell
1,007
-1,928
-66% -$248K ﹤0.01% 3431
2021
Q2 		$509K Buy
+2,935
New +$664K ﹤0.01% 3158
2019
Q4 		– Sell
-70
Closed -$22K – 3405
2019
Q3 		$22K Sell
70
-34
-33% -$29.3K ﹤0.01% 3409
2019
Q2 		$111K Buy
104
+17
+20% +$23.4K ﹤0.01% 3388
2019
Q1 		$107K Buy
87
+52
+149% +$61.8K ﹤0.01% 3374
2018
Q4 		$28K Buy
+35
New +$59.7K ﹤0.01% 3420
2015
Q1 		– Hold
0
– -$22K – 3401
2014
Q4 		– Hold
0
– – – 3413

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's TRAW Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Traws Pharma (TRAW) in Q2 2022, closing a stake of 894 shares — an estimated $41K sold.

Dimensional Fund Advisors first reported a position in TRAW in Q4 2018 and held it in 8 quarters. The position peaked at $509K in Q2 2021. 30 funds tracked by Wall St. Rank hold TRAW as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Traws Pharma position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 894 Traws Pharma shares in Q2 2022, an estimated $41K.
  • Dimensional Fund Advisors first reported a position in Traws Pharma in Q4 2018 and held it in 8 quarters.
  • Dimensional Fund Advisors's Traws Pharma position peaked at $509K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.